| | Control | RNAi |
---|
| | Mock (%) | Scramble (%) | SRCAP A (%) | SRCAP B (%) |
---|
Metaphase | MS | 4.38 ± 2.58 | 0 | 6.21 ± 4.43 ***(scramble) | 0 |
CM | 15.31 ± 14.45 | 3.30 ± 5.80 | 57.36 ± 16.78*** | 47.90 ± 5.90*** |
ASM | 2.25 ± 0.45 | 0 | 29.93 ± 2.80*** | 20.8 ± 5.90*** |
Telophase | CB | 6.00 ± 1.97 | 1.00 ± 1.70 | 8.45 ± 4.96 *(mock), ***(scramble) | 38.20 ± 3.60*** |
LIB | 1.87 ± 0.67 | 8.10 ± 1.10 | 28.69 ± 9.21** | 23.80 ± 3.60*** |
MC | 2.16 ± 0.49 | 1.90 ± 1.70 | 14.21 ± 3.74*** | 9.30 ± 2.30*** |
- CB, chromatin bridges; CM, chromosome misalignments; LIB, long intercellular bridges; MC, multinucleated cells; MS, multipolar Spindles
- The results are expressed as mean ± SD values from three independent replicate experiments: *P < 0.05; **P < 0.005; and ***P < 0.0005 compared with the controls group by Fisher’s exact test
- Notably, MS found in cells treated with SRCAP A are statistically significant (***) compared to scramble, but not to mock. CB show different statistically significant levels depending on comparison between SRCAP A and scramble (***) or mock (*)